142 related articles for article (PubMed ID: 11565810)
1. Tenascin-C splice variant adhesive/anti-adhesive effects on chondrosarcoma cell attachment to fibronectin.
Ghert MA; Qi WN; Erickson HP; Block JA; Scully SP
Cell Struct Funct; 2001 Jun; 26(3):179-87. PubMed ID: 11565810
[TBL] [Abstract][Full Text] [Related]
2. The clinical significance of tenascin-C splice variant expression in chondrosarcoma.
Ghert MA; Jung ST; Qi W; Harrelson JM; Erickson HP; Block JA; Scully SP
Oncology; 2001; 61(4):306-14. PubMed ID: 11721178
[TBL] [Abstract][Full Text] [Related]
3. Tenascin-C expression and distribution in cultured human chondrocytes and chondrosarcoma cells.
Ghert MA; Qi WN; Erickson HP; Block JA; Scully SP
J Orthop Res; 2002 Jul; 20(4):834-41. PubMed ID: 12168675
[TBL] [Abstract][Full Text] [Related]
4. Cell-adhesive responses to tenascin-C splice variants involve formation of fascin microspikes.
Fischer D; Tucker RP; Chiquet-Ehrismann R; Adams JC
Mol Biol Cell; 1997 Oct; 8(10):2055-75. PubMed ID: 9348542
[TBL] [Abstract][Full Text] [Related]
5. Binding of tenascin-C to soluble fibronectin and matrix fibrils.
Chung CY; Zardi L; Erickson HP
J Biol Chem; 1995 Dec; 270(48):29012-7. PubMed ID: 7499434
[TBL] [Abstract][Full Text] [Related]
6. mRNA expression and protein distribution of fibronectin splice variants and high-molecular weight tenascin-C in different phases of human fracture healing.
Kilian O; Dahse R; Alt V; Zardi L; Hentschel J; Schnettler R; Kosmehl H
Calcif Tissue Int; 2008 Aug; 83(2):101-11. PubMed ID: 18663401
[TBL] [Abstract][Full Text] [Related]
7. The adhesion modulating properties of tenascin-W.
Brellier F; Martina E; Chiquet M; Ferralli J; van der Heyden M; Orend G; Schittny JC; Chiquet-Ehrismann R; Tucker RP
Int J Biol Sci; 2012; 8(2):187-94. PubMed ID: 22211116
[TBL] [Abstract][Full Text] [Related]
8. Specific processing of tenascin-C by the metalloprotease meprinbeta neutralizes its inhibition of cell spreading.
Ambort D; Brellier F; Becker-Pauly C; Stöcker W; Andrejevic-Blant S; Chiquet M; Sterchi EE
Matrix Biol; 2010 Jan; 29(1):31-42. PubMed ID: 19748582
[TBL] [Abstract][Full Text] [Related]
9. Expansion of the nonadherent myeloid cell population by monoclonal antibodies against tenascin-C in murine long-term bone marrow cultures.
Talts JF; Falk M; Ekblom M
Exp Hematol; 1998 Jul; 26(7):552-61. PubMed ID: 9657129
[TBL] [Abstract][Full Text] [Related]
10. Analysis of combinatorial variability reveals selective accumulation of the fibronectin type III domains B and D of tenascin-C in injured brain.
Dobbertin A; Czvitkovich S; Theocharidis U; Garwood J; Andrews MR; Properzi F; Lin R; Fawcett JW; Faissner A
Exp Neurol; 2010 Sep; 225(1):60-73. PubMed ID: 20451518
[TBL] [Abstract][Full Text] [Related]
11. Expression of tenascin-C by human endometrial adenocarcinoma and stroma cells: heterogeneity of splice variants and induction by TGF-beta.
Vollmer G; Tan MI; Wünsche W; Frank K
Biochem Cell Biol; 1997; 75(6):759-69. PubMed ID: 9599665
[TBL] [Abstract][Full Text] [Related]
12. Tenascin-C promotes cell survival by activation of Akt in human chondrosarcoma cell.
Jang JH; Chung CP
Cancer Lett; 2005 Nov; 229(1):101-5. PubMed ID: 16157221
[TBL] [Abstract][Full Text] [Related]
13. Expression of tenascin-C splice variants by human skin cells.
Latijnhouwers MA; de Jongh GJ; Bergers M; de Rooij MJ; Schalkwijk J
Arch Dermatol Res; 2000 Sep; 292(9):446-54. PubMed ID: 11000288
[TBL] [Abstract][Full Text] [Related]
14. Concerted action of tenascin-C domains in cell adhesion, anti-adhesion and promotion of neurite outgrowth.
Fischer D; Brown-Lüdi M; Schulthess T; Chiquet-Ehrismann R
J Cell Sci; 1997 Jul; 110 ( Pt 13)():1513-22. PubMed ID: 9224768
[TBL] [Abstract][Full Text] [Related]
15. The alternatively spliced domain TnFnIII A1A2 of the extracellular matrix protein tenascin-C suppresses activation-induced T lymphocyte proliferation and cytokine production.
Puente Navazo MD; Valmori D; Rüegg C
J Immunol; 2001 Dec; 167(11):6431-40. PubMed ID: 11714809
[TBL] [Abstract][Full Text] [Related]
16. Tenascin-C contains distinct adhesive, anti-adhesive, and neurite outgrowth promoting sites for neurons.
Götz B; Scholze A; Clement A; Joester A; Schütte K; Wigger F; Frank R; Spiess E; Ekblom P; Faissner A
J Cell Biol; 1996 Feb; 132(4):681-99. PubMed ID: 8647898
[TBL] [Abstract][Full Text] [Related]
17. Human tenascin-C: identification of a novel type III repeat in oral cancer and of novel splice variants in normal, malignant and reactive oral mucosae.
Mighell AJ; Thompson J; Hume WJ; Markham AF; Robinson PA
Int J Cancer; 1997 Jul; 72(2):236-40. PubMed ID: 9219826
[TBL] [Abstract][Full Text] [Related]
18. Mitogenic and adhesive effects of tenascin-C on human hematopoietic cells are mediated by various functional domains.
Seiffert M; Beck SC; Schermutzki F; Müller CA; Erickson HP; Klein G
Matrix Biol; 1998 Apr; 17(1):47-63. PubMed ID: 9628252
[TBL] [Abstract][Full Text] [Related]
19. Interference of tenascin-C with syndecan-4 binding to fibronectin blocks cell adhesion and stimulates tumor cell proliferation.
Huang W; Chiquet-Ehrismann R; Moyano JV; Garcia-Pardo A; Orend G
Cancer Res; 2001 Dec; 61(23):8586-94. PubMed ID: 11731446
[TBL] [Abstract][Full Text] [Related]
20. Tenascin-R (J1 160/180 inhibits fibronectin-mediated cell adhesion--functional relatedness to tenascin-C.
Pesheva P; Probstmeier R; Skubitz AP; McCarthy JB; Furcht LT; Schachner M
J Cell Sci; 1994 Aug; 107 ( Pt 8)():2323-33. PubMed ID: 7527058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
